Search Results - "Burchardt, E R"

Refine Results
  1. 1

    Laminin, hyaluronan, tenascin-C and type VI collagen levels in sera from patients with malignant melanoma by Burchardt, E. R., Hein, R., Bosserhoff, A. K.

    Published in Clinical and experimental dermatology (01-09-2003)
    “…Summary In this study, hyaluronan, laminin‐1, tenascin‐C and type VI collagen were measured in the sera of patients with stage I/II and stage IV melanoma. A…”
    Get full text
    Journal Article
  2. 2

    Autologous bone marrow-derived stem cell therapy in combination with TMLR. A novel therapeutic option for endstage coronary heart disease: report on 2 cases by Klein, H-M, Ghodsizad, A, Borowski, A, Saleh, A, Draganov, J, Poll, L, Stoldt, V, Feifel, N, Piecharczek, C, Burchardt, E R, Stockschläder, M, Gams, E

    Published in The Heart surgery forum (01-01-2004)
    “…We report 2 cases in which patients with coronary heart disease not amenable for conventional revascularization underwent transmyocardial laser…”
    Get more information
    Journal Article
  3. 3

    Favorable combination effects of the leukotriene synthesis inhibitor BAY X 1005 and dexamethasone on edema formation in the arachidonic acid-induced mouse ear inflammation test by Burchardt, E.R., Müller-Peddinghaus, R.

    “…The effects of a combination of the leukotriene synthesis inhibitor (LSI) BAY X 1005 with the glucocorticosteroid dexamethasone were studied in the arachidonic…”
    Get full text
    Journal Article
  4. 4

    Intramyocardial implantation of CD133+ stem cells improved cardiac function without bypass surgery by Klein, H M, Ghodsizad, A, Marktanner, R, Poll, L, Voelkel, T, Mohammad Hasani, M R, Piechaczek, C, Feifel, N, Stockschlaeder, M, Burchardt, E R, Kar, B J, Gregoric, I, Gams, E

    Published in The Heart surgery forum (01-01-2007)
    “…Cell transplantation for myocardial regeneration has been shown to have beneficial effects on cardiac function after myocardial infarction. Most clinical…”
    Get more information
    Journal Article
  5. 5

    Antiedematous effects of combination therapies with the leukotriene synthesis inhibitor BAY X 1005 in the archidonic acid-induced mouse ear inflammation test by Burchardt, E.R., Müller-Peddinghaus, R.

    “…The leukotriene synthesis inhibitor (LSI) BAY X 1005 was tested in the arachidonic acid (AA)-induced mouse ear inflammation test (AA-MEIT) alone and in…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Intraoperative isolation and processing of BM-derived stem cells by Ghodsizad, A., Klein, H.-M., Borowski, A., Stoldt, V., Feifel, N., Voelkel, T., Piechaczek, C.H., Burchardt, E.R., Stockschläder, M., Gams, E.

    Published in Cytotherapy (Oxford, England) (01-10-2004)
    “…To improve tissue regeneration of ischemic myocardium, autologous bone marrow-derived stem cells have been injected intramyocardially in five patients…”
    Get full text
    Journal Article
  8. 8

    Autocrine expression of activated transforming growth factor-beta(1) induces apoptosis in normal rat liver by Schrum, L W, Bird, M A, Salcher, O, Burchardt, E R, Grisham, J W, Brenner, D A, Rippe, R A, Behrns, K E

    “…The aim of this study was to determine the differential effects of latent and activated transforming growth factor (TGF)-beta(1) in growth control of normal…”
    Get more information
    Journal Article
  9. 9
  10. 10

    Assessment of G-CSF and GM-CSF mRNA expression in peripheral blood mononuclear cells from patients with severe congenital neutropenia and in human myeloid leukemic cell lines by Bernhardt, T M, Burchardt, E R, Welte, K

    Published in Experimental hematology (01-01-1993)
    “…Patients with severe congenital neutropenia (SCN), also called Kostmann syndrome, are unable to generate sufficient peripheral blood granulocytes owing to an…”
    Get more information
    Journal Article
  11. 11

    The role of TGFβ1 in initiating hepatic stellate cell activation in vivo by Hellerbrand, Claus, Stefanovic, Branko, Giordano, Frank, Burchardt, Elmar R, Brenner, David A

    Published in Journal of hepatology (1999)
    “…Background/Aims: The activation of hepatic stellate cells is a key initiating event in hepatic fibrogenesis. Although TGFβ1 is a potent inducer of collagen…”
    Get full text
    Journal Article
  12. 12
  13. 13
  14. 14

    Characterization of the interaction between alpha CP sub(2) and the 3'-untranslated region of collagen alpha 1(I) mRNA by Lindquist, J N, Kauschke, S G, Stefanovic, B, Burchardt, E R, Brenner, DA

    Published in Nucleic acids research (01-11-2000)
    “…Activated hepatic stellate cells produce increased type I collagen in hepatic fibrosis. The increase in type I collagen protein results from an increase in…”
    Get full text
    Journal Article
  15. 15

    Attenuation of CCl(4)-induced hepatic fibrosis by GdCl(3) treatment or dietary glycine by Rivera, C A, Bradford, B U, Hunt, K J, Adachi, Y, Schrum, L W, Koop, D R, Burchardt, E R, Rippe, R A, Thurman, R G

    “…The role of Kupffer cells in CCl(4)-induced fibrosis was investigated in vivo. Male Wistar rats were treated with phenobarbital and CCl(4) for 9 wk, and a…”
    Get more information
    Journal Article
  16. 16

    The role of TGFbeta1 in initiating hepatic stellate cell activation in vivo by Hellerbrand, C, Stefanovic, B, Giordano, F, Burchardt, E R, Brenner, D A

    Published in Journal of hepatology (01-01-1999)
    “…The activation of hepatic stellate cells is a key initiating event in hepatic fibrogenesis. Although TGFbeta1 is a potent inducer of collagen alpha1(I)…”
    Get full text
    Journal Article
  17. 17

    Interaction Properties of the Procollagen C-proteinase Enhancer Protein Shed Light on the Mechanism of Stimulation of BMP-1 by Ricard-Blum, Sylvie, Bernocco, Simonetta, Font, Bernard, Moali, Catherine, Eichenberger, Denise, Farjanel, Jean, Burchardt, Elmar R., van der Rest, Michel, Kessler, Efrat, Hulmes, David J.S.

    Published in The Journal of biological chemistry (13-09-2002)
    “…Procollagen C-proteinase enhancer (PCPE) is an extracellular matrix glycoprotein that binds to the C-propeptide of procollagen I and can enhance the activities…”
    Get full text
    Journal Article
  18. 18

    Enzyme immunoassay for the measurement of human tenascin-C on the Bayer Immuno 1™ analyzer by Ropers, Tanja, Kroll, Werner, Becka, Michael, Voelker, Michael, Burchardt, Elmar R., Schuppan, DetlefF, Gehrmann, Mathais

    Published in Clinical biochemistry (01-02-2000)
    “…Objectives: To evaluate a new tenascin-C assay performed on the Bayer Immuno 1™ system. Design and methods: The precision was measured using three levels of…”
    Get full text
    Journal Article
  19. 19

    Epitope-specific monoclonal antibodies against human C-terminal procollagen alpha1(III)-propeptide by Burchardt, E R, Heke, M, Kauschke, S G, Harjes, P, Kohlmeyer, J, Kroll, W, Schauer, M, Schroeder, W, Voelker, M

    Published in Matrix biology (01-12-1998)
    “…We have generated monoclonal antibodies against recombinant C-terminal human procollagen alpha1(III) propeptide (PIIICP), produced in E. coli in high yields…”
    Get full text
    Journal Article
  20. 20

    Characterization of the interaction between alphaCP(2) and the 3'-untranslated region of collagen alpha1(I) mRNA by Lindquist, J N, Kauschke, S G, Stefanovic, B, Burchardt, E R, Brenner, D A

    Published in Nucleic acids research (01-11-2000)
    “…Activated hepatic stellate cells produce increased type I collagen in hepatic fibrosis. The increase in type I collagen protein results from an increase in…”
    Get full text
    Journal Article